Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung

Lung carcinoids occur sporadically and rarely in association with multiple endocrine neoplasia type 1 (MEN1). There are no well defined genetic abnormalities known to occur in these tumors. We studied 11 sporadic lung carcinoids for loss of heterozygosity (LOH) at the locus of the MEN1 gene on chromosome 11q13, and for mutations of the MEN1 gene using dideoxy fingerprinting. Additionally, a lung carcinoid from a MEN1 patient was studied. In four of 11 (36%) sporadic tumors, both copies of the MEN1 gene were inactivated. All four tumors showed the presence of a MEN1 gene mutation and loss of the other allele. Observed mutations included a 1 bp insertion, a 1 bp deletion, a 13 bp deletion and a single nucleotide substitution affecting a donor splice site. Each mutation predicts truncation or potentially complete loss of menin. The remaining seven tumors showed neither the presence of a MEN1 gene mutation nor 11q13 LOH. The tumor from the MEN1 patient showed LOH at chromosome 11q13 and a complex germline MEN1 gene mutation. The data implicate the MEN1 gene in the pathogenesis of sporadic lung carcinoids, representing the first defined genetic alteration in these tumors.      

慢性胰腺炎K—ras基因突变的临床病理学意义

目的：探讨慢性胰腺炎K－ras基因突变的临床病理学意义。方法：9例手术切除的慢性胰腺炎的石蜡标本,用微解剖法分离慢性胰腺炎的胰导管上皮粘液细胞增生灶,提取,扩增DNA,用ASO斑点杂交检测K－ras基因第12密码子的碱基序列。对9例接受手术治疗的病人进行长期随访,结果：9例慢性胰腺炎中4例有明显的胰导管上皮粘液细胞增生,其中2例被检出GAT型突变,分别占全组和有胰管上皮粘液细胞增生的22％和505,两个突变病例分别是接受了胰体尾切除和胰头十二指肠切除手术,术后分别随访17年和10年,没有发现任何恶变迹象,结构：慢性胰腺为可以检出K－ras基因突变,发生了K－ras基因突变的慢性胰腺炎上皮粘液细胞增生灶,未必一定发生为胰腺癌,胰液、粪便、末梢血液和尿液的检测,以及胰腺组织细针刺液检出K－ras基因突变,对胰腺癌的诊断有重要参考价值,但不应视为胰腺癌的确诊依据。     

A prognostic immune predictor,HLA-DRA,plays diverse roles in non-muscle invasive and muscle invasive bladder cancer

BackgroundThere is an increasing demand for prognostic immune biomarkers of cancer. The prognostic significance of immune markers has been shown for various cancers, but biomarkers of bladder cancer (BCa) have not been fully evaluated. To clarify the role of human leukocyte antigen DR alpha chain (HLA-DRA) in BCa development, we examined expression of HLA-DRA mRNA in tissue samples of non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC).Materials and MethodsTissues of 96 NMIBC, 43 MIBC and 59 controls comprising noncancerous BCa surrounding tissues were used to examine the expression of HLA-DRA gene by real-time polymerase chain reaction. The expression of up-stream genes regulating HLA-DRA were also measured to explain the role of HLA-DRA in BCa.ResultsPatients with high grade NMIBC showed higher expression of HLA-DRA than those with low grade NMIBC (P < 0.05). In addition, NMIBC patients who progressed to MIBC showed high expression of HLA-DRA mRNA. Kaplan-Meier analysis showed that NMIBC patients with low expression of HLA-DRA had better progression-free survival than those with high expression (P = 0.004). Moreover, the expression of genes regulating HLA-DRA varied in NMIBC and MIBC, indicating a different immunoregulation effect of HLA-DRA in both cancers.ConclusionsHigh expression of HLA-DRA in NMIBC patients has implications for patient stratification strategies, as well as for BCa tumor immunology.     

A novel mis-sense mutation (G1381A) in the G6PD gene identified in a Chinese man

Objective　To detect new mutations among 29 glucose-6-phosphate dehydrogenase (G6PD) deficient individuals from Yunnan province. Methods　The nitroblue tetrazolium (NBT) method was used to screen G6PD deficient individuals. Mutation was identified by single strand conformation polymorphism (SSCP), amplification created restriction site (ACRS), amplification refractory mutation system (ARMS) and DNA sequencing. Results　Among 29 cases, 18 cases of G1388A, 1 case of C1004A, and 1 case of G1381A were identified. Nine cases remained to be defined. The G1381A mutation is a novel mis-sense mutation, with a substitution of threonine for alanine (A461T). The resultant G6PD had reduced enzymatic activity. In addition, G1381A caused a restriction site of Stu I to disappear, providing a rapid method for the detection of this mutation. Conclusion　A novel mis-sense mutation G1381A was found. This mutation results in a substitution of threonine for alanine, producing enzyme with reduced activity. The loss of the Stu I restriction site offers a rapid method for the detection of this mutation.     

心肌肌钙蛋白T在小儿心肌炎中的动态变化及其与心功能的相关性

目的研究心肌肌钙蛋白T(cardiactroponinT,cTnT)在心肌炎中的动态变化及与心功能的相关性.方法应用夹心层免疫吸附法测定30例心肌炎,20例疑似心肌炎及30例正常对照cTnT和肌酸磷酸激酶(creatinekinase,CK)及同功酶CK-MB,同步进行心功能测定.结果心肌炎组cTnT明显高于疑似心肌炎组及对照组,且心肌炎组治疗前明显高于治疗后,疑似心肌炎组与对照组无显著差异.cTnT与心脏收缩功能(CI,EF,ACT)均呈负相关.cTnT的敏感性为76.67%,特异性为96.67%.结论cTnT对心肌损害的敏感性及特异性均高于CK和CK-MB,其动态变化提示心肌病变的轻重及预后.cTnT与心脏收缩功能呈负相关,即cTnT越高,收缩功能越差.     

STUDY ON MODIFIED COLD STORAGE METHOD OF RAT LIVERS WITH SELF-MADE HYD SOLUTION

ＩＮＴＲＯＤＵＣＴＩＯＮ　　Ｔｈｅｍｅｔｈｏｄｏｆｃｏｌｄｌｉｖｅｒｐｒｅｓｅｒｖａｔｉｏｎｉｓａｃｒｕｃｉａｌｌｉｍｉｔ ｉｎｇｆａｃｔｏｒｉｎｔｈｅｄｕｒａｔｉｏｎｏｆｌｉｖｅｒｐｒｅｓｅｒｖａｔｉｏｎ .Ｅｘｐｅｒｉｍｅｎｔａｌｅｖｉｄｅｎｃｅｈａｓｓｈｏｗｎｔｈａｔｎｏｎｐａｒｅｎｃｈｙｍａｌｃｅｌｌｓａｒｅｍｏｒｅｖｕｌｎｅｒａｂｌｅｔｏｈｙｐｏｔｈｅｒｍｉｃｓｔｏｒａｇｅｔｈａｎｈｅｐａｔｏｃｙｔｅ,ｉｎｄｉｃａｔｉｎｇｔｈａｔｐｒｏｔｅｃｔｉｏｎｏｆｔｈｅｍｉｃｒｏｖａｓｃｕｌａｔｕｒ…     

核桃楸果中微量元素的分析

用火焰原子吸收分光光度法（ＡＡＳ）测定核桃楸果中的１１种微量元素。结果Ｃｄ、Ｃｏ元素未检出,Ｚｎ、Ｃｕ、Ｍｎ、Ｓｅ等人体必需元素较丰富。酒提取液中Ｚｎ、Ｃｕ、Ｆｅ、Ｍｎ、Ｓｅ的溶出率在４％～２４％之间,Ｐｂ未检出     

某些酶活性变化对评价生长发育期大鼠锌营养的意义

雄性断乳大鼠随机分为低锌组、高锌组、正常锌组和低锌组的高锌饲料对饲组。喂相应饲料２０天后,低锌组的部分大鼠改喂高锌饲料（低 高锌组）,高锌组的部分大鼠改喂低锌饲料（高 低锌组）。分别于实验期０、２０、５０和７０天时处死。测定血浆碱性磷酸酶、５′ 核苷酸酶和铜 锌型超氧化物歧化酶活性、血浆锌及肾脏锌含量变化,以考核它们对评价锌营养状况的意义。结果表明：碱性磷酸酶、５′ 核苷酸酶以及血浆锌浓度变化对缺锌或／和补锌反应敏感。短期缺锌时（２０天）碱性磷酸酶活性就显著降低,并随缺锌时间延长该酶活性持续降低,而短期补锌（３０天）后又能显著增加其活性。受锌营养状况影响,血浆５′ 核苷酸酶活性也有类似的变化趋势。但这些酶活性又受增龄因素的影响,即随实验期增加,正常锌组碱性磷酸酶活性呈降低趋势,而５′ 核苷酸酶活性则呈增加趋势。长期严重缺锌可以影响铜 锌型超氧化物歧化酶活性;补锌后在实验期内未见到它的活性显著增加。随实验期增加,低锌组血浆锌持续降低,５０天时,显著低于高锌组;７０天时,低锌组和高 低锌组的血浆锌也显著低于高锌和低 高锌组。这些结果提示,碱性磷酸酶和５′ 核苷酸酶的活性及血浆锌变化对评价大鼠锌营养状况有一定的意?     

开郁清胃颗粒对2型糖尿病胰岛素敏感性的影响

目的：通过临床观察初步探讨开郁清胃颗粒对2型糖尿病患者胰岛素敏感性的影响。方法：以二甲双胍为对照，观察60例2型糖尿病患者治疗前后体重及腰臀围、症状积分、血糖、胰岛素、胰岛素敏感指数、血脂、焦虑及抑郁积分等指标的变化。结果：开郁清胃颗粒对2型糖尿病患者的血糖、血脂紊乱有明显的改善作用，并能减轻体重，提高胰岛素敏感性，改善焦虑及抑郁状态。结论：开郁清胃颗粒增加2型糖尿病患者的胰岛素敏感性可能与改善血脂紊乱，改善焦虑、抑郁状态及减轻体重等有关。     

Black tea and mammary gland carcinogenesis by 7,12- dimethylbenz[a]anthracene in rats fed control or high fat diets

Epidemiological studies suggest that tea may reduce cancer risk, and in laboratory rodents, chemopreventive effects of tea or purified extracts of tea have been demonstrated in lung, gastrointestinal tract and skin. There is some evidence of chemoprevention by tea in the mammary gland, but the data are not conclusive. In order to evaluate more fully the possible influence of black tea on 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary gland tumors in the female S-D (Sprague-Dawley) rat, three large studies were performed: experiment 1, tumorigenesis in rats fed AIN-76A diet and given 25 mg/kg DMBA and 1.25 or 2.5% whole tea extract or water to drink; experiment 2, tumorigenesis in rats given 15 mg/kg DMBA and the same diet and fluids as in experiment 1; experiment 3, tumorigenesis in rats fed control or HF (high fat, corn oil) diet and given 15 mg/kg DMBA and 2% tea or water to drink. Tea was given throughout the experiment; DMBA was given by gastric gavage at 8 weeks of age. There was no consistent effect of tea on tumorigenesis in rats fed AIN-76A diet; there was, however, evidence in experiment 3 of a reduction of tumorigenesis by tea in rats fed the HF diet. In experiment 3, rats fed the HF diet and given water showed the expected increase in tumor burden (number and weight) compared with rats fed control diet. However, rats fed the HF diet and given 2% tea showed no increase in tumor burden; their tumor burden was significantly lower than in rats fed the HF diet and given water (P < 0.01) and was not different from rats fed control diet and given water or tea. In addition, in experiment 3, the number of malignant tumors per tumor- bearing rat was increased by the HF diet in water-drinking rats (P < 0.01) but not in tea-drinking rats. Therefore, it appears that tea partially blocked the promotion of DMBA-induced mammary tumorigenesis by the HF diet.